P. Spagnolo (Padova (PD), Italy), K. Moor (Rotterdam, Netherlands)
This session is built from abstracts published on the ERS Congress platform from 23 August, in a PowerPoint format with a pre-recorded audio narration. The live session is scheduled from September 5-7 and each presenter will have a 5-minutes live, slide show presentation followed at the end of the session by 30-minutes general discussion.
Mineral exposures in pediatric sarcoidosis
N. Nathan (Paris, France), M. Montagne (Paris, France), O. Macchi (Paris, France), P. Rosental (Paris, France), S. Chauveau (Bobigny, France), F. Jeny (Bobigny, France), L. Sesé (Bobigny, France), R. Abou Taam (Paris, France), J. Brouard (Caen, France), M. Catinon (Villeurbanne, France), C. Chapelon-Abric (Paris, France), F. Cohen Aubart (Paris, France), C. Delacourt (Paris, France), C. Delestrain (Créteil, France), A. Deschildre (Lille, France), A. Dossier (Paris, France), R. Epaud (Créteil, France), J. Haroche (Paris, France), V. Houdouin (Paris, France), D. Israel-Biet (Paris, France), K. Juvin (Paris, France), S. Le Jeune (Bobigny, France), F. Lionnet (Paris, France), U. Meinzer (Paris, France), M. Mittaine (Toulouse, France), H. Nunes (Bobigny, France), S. Mattioni (Paris, France), J. Naccache (Paris & Suresnes, France), M. Odièvre (Paris, France), M. Vincent (Villeurbanne, France), A. Clement (Paris, France), D. Valeyre (Paris, France), C. Cavalin (Paris & Noisy le Grand, France)
|    |
Associations between occupational and environmental exposures and organ involvement in sarcoidosis: a retrospective case-case analysis
S. Ronsmans (Leuven, Belgium), E. Vandebroek (Leuven, Belgium), S. Keirsbilck (Leuven, Belgium), B. Nemery (Leuven, Belgium), P. Hoet (Leuven, Belgium), S. Vanderschueren (Leuven, Belgium), W. Wuyts (Leuven, Belgium), J. Yserbyt (Leuven, Belgium)
| |
mTORC1 signaling in granulomatous lesions is not specific for sarcoidosis
R. Kraaijvanger (Nieuwegein, Netherlands), E. Beijer (Nieuwegein, Netherlands), C. Seldenrijk (Nieuwegein, Netherlands), J. Damen ('s-Hertogenbosch, Netherlands), M. Veltkamp (Nieuwegein, Netherlands)
| |
Polymorphism in C-C Chemokine Receptor 5 (CCR5) increases susceptibility to Löfgren’s syndrome and alters receptor expression as well as functional response.
B. Karakaya (Nieuwegein, Netherlands), C. Van Moorsel (Nieuwegein, Netherlands), M. Veltkamp (Nieuwegein, Netherlands), C. Benschop (Nieuwegein, Netherlands), K. Kazemier (Utrecht, Netherlands), A. Van Der Helm-Van Mil (Leiden, Netherlands), T. Huizinga (Leiden, Netherlands), J. Grutters (Nieuwegein, Netherlands), G. Rijkers (Middelburg, Netherlands)
| |
Bioinformatic identification of orthologous granuloma formation genes in Cutibacterium acnes associated with sarcoidosis
Y. Hodzhev (Sofia, Bulgaria), B. Tsafarova (Sofia, Bulgaria), V. Tolchkov (Sofia, Bulgaria), S. Panaiotov (Sofia, Bulgaria)
| |
The pulmonary bacterial and fungal microbiota in sarcoidosis patients.
K. Knudsen (Bergen, Norway), S. Lehmann (Bergen, Norway), R. Nielsen (Bergen, Norway), S. Tangedal (Bergen, Norway), E. Martinsen (Bergen, Norway), T. Eagan (Bergen, Norway)
| |
FeV1 and body weight weight on LCQ in sarcoidosis patients
B. Frye (Freiburg, Germany), D. Soriano (Freiburg, Germany), E. Farin (Freiburg, Germany), J. Müller-Quernheim (Freiburg, Germany), J. Schupp (New Haven, United States of America)
| |
Effects of Infliximab on FDG Uptake and Small Fiber Neuropathy Symptoms in Sarcoidosis Patients
L. Raasing (Nieuwegein, Netherlands), O. Vogels (Nieuwegein, Netherlands), M. Veltkamp (Nieuwegein, Netherlands), J. Grutters (Nieuwegein, Netherlands)
| |
Long-term response to prednisone in newly treated patients with pulmonary sarcoidosis
V. Kahlmann (Rotterdam, Netherlands), C. Moor (Rotterdam, Netherlands), C. Broos (Rotterdam, Netherlands), J. In ’T Veen (Rotterdam, Netherlands), M. Overbeek (The Hague, Netherlands), M. Grootenboers (Breda, Netherlands), R. Heller (Rotterdam, Netherlands), R. Mostard (Heerlen, Netherlands), M. Wijsenbeek (Rotterdam, Netherlands)
| |
Late Breaking Abstract - Immunomodulatory protein ATYR1923 disrupts an in vitro model of sarcoid granuloma formation
S. Paz (San Diego, United States of America), M. Julian (Columbus, United States of America), D. Siefker (San Diego, United States of America), E. Escobedo (San Diego, United States of America), C. Polizzi (San Diego, United States of America), M. Ferrer (San Diego, United States of America), L. Guy (San Diego, United States of America), C. Burkart (San Diego, United States of America), R. Adams (San Diego, United States of America), L. Nangle (San Diego, United States of America), E. Crouser (San Diego, United States of America)
| |
Discussion
| |